Edward Agura

Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial

Craig H. Moskowitz, Auayporn Nademanee, Tamás Masszi et al. · The Lancet · 2015 · 734 citations · Full text

Medicine, Immunology, Oncology +15

Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation

Kenneth I. Weinberg, Bruce R. Blazar, John E. Wagner et al. · Blood · 2001 · 420 citations · Full text

Life Sciences, Hematology, Immunology +14

Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies

Mohamed L. Sorror, Brenda M. Sandmaier, Barry E. Storer et al. · JAMA · 2011 · 320 citations · Full text

Medicine, Geriatric Medicine, Hematology +15

Five-Year Follow-Up of Patients With Advanced Chronic Lymphocytic Leukemia Treated With Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning

Mohamed L. Sorror, Barry E. Storer, Brenda M. Sandmaier et al. · Journal of Clinical Oncology · 2008 · 278 citations · Full text

Medicine, Hematology, Oncology +15

Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma

Michael B. Maris, Brenda M. Sandmaier, Barry E. Storer et al. · Blood · 2004 · 255 citations

Medicine, Hematology, Oncology +12